Fox Run Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$958K Buy
+52,175
New +$861K 0.11% 325
2026
Q1
– Sell
-11,522
Closed -$135K – 1129
2025
Q4
$135K Sell
11,522
-5,866
-34% -$63.3K 0.02% 844
2025
Q3
$134K Buy
+17,388
New +$122K 0.02% 848
2024
Q4
– Sell
-26,468
Closed -$390K – 1071
2024
Q3
$390K Buy
+26,468
New +$414K 0.09% 450
2024
Q1
– Sell
-11,539
Closed -$187K – 973
2023
Q4
$187K Sell
11,539
-3,720
-24% -$60.9K 0.05% 640
2023
Q3
$188K Sell
15,259
-23,313
-60% -$347K 0.06% 572
2023
Q2
$620K Sell
38,572
-9,239
-19% -$152K 0.17% 225
2023
Q1
$832K Buy
47,811
+30,230
+172% +$431K 0.27% 101
2022
Q4
$162K Buy
+17,581
New +$164K 0.07% 515
2022
Q2
– Sell
-15,421
Closed -$187K – 673
2022
Q1
$187K Buy
+15,421
New +$325K 0.1% 421
2021
Q4
– Sell
-10,500
Closed -$507K – 625
2021
Q3
$507K Buy
+10,500
New +$486K 0.32% 73
2019
Q4
– Sell
-11,727
Closed -$224K – 481
2019
Q3
$224K Buy
+11,727
New +$275K 0.2% 270
2019
Q1
– Sell
-15,260
Closed -$192K – 619
2018
Q4
$192K Buy
+15,260
New +$227K 0.1% 420
2016
Q3
– Sell
-21,300
Closed -$171K – 616
2016
Q2
$171K Buy
+21,300
New +$171K 0.08% 464

Other funds holding NEO

Fox Run Management's NEO Position: Q3 2026 in Review

Fox Run Management opened a new position in NeoGenomics (NEO) in Q3 2026: 52,175 shares worth $958K. The stake represents 0.11% of the portfolio and ranks #325 among its holdings. This is a return to the name: Fox Run Management previously reported a position in NEO as recently as Q4 2025.

Fox Run Management first reported a position in NEO in Q2 2016 and has held it in 14 quarters since. 231 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Fox Run Management held 52,175 shares of NeoGenomics worth $958K as of Q3 2026.
  • NeoGenomics was a new Fox Run Management position in Q3 2026.
  • NeoGenomics made up 0.11% of Fox Run Management's portfolio in Q3 2026, its #325 holding.
  • Fox Run Management first reported a position in NeoGenomics in Q2 2016 and has held it in 14 quarters since.
  • 231 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.